Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Waring

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
American Journal of Obstetrics and Gynecology|November 1, 1994
Leukemia inhibitory factor: association with intraamniotic infectionP M Waring, R Romero, N Laham, et al.
Histopathology|July 18, 2006
Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clonesM B Loughrey, V Beshay, A Dobrovic, et al.
Journal of Clinical Pathology|June 25, 2005
Gastrointestinal stromal tumour treated with neoadjuvant imatinibM B Loughrey, C Mitchell, G B Mann, et al.
Arthritis and Rheumatism|July 1, 1993
Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritidesP M Waring, G J Carroll, D A Kandiah, et al.
Clinical and Experimental Immunology|December 1, 1995
Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemiaP M Waring, J Presneill, D W Maher, et al.
Critical Care Medicine|November 5, 1999
Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study GroupJ H Reeves, W W Butt, F Shann, et al.
Familial Cancer|April 25, 2007
Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancerM B Loughrey, P M Waring, A Tan, et al.
Critical Care Medicine|August 2, 2000
Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortalityJ J Presneill, P M Waring, J E Layton, et al.
Histopathology|July 18, 2006
KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinibM B Loughrey, M Trivett, V Beshay, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
American Journal of Obstetrics and Gynecology|November 1, 1994
Leukemia inhibitory factor: association with intraamniotic infectionP M Waring, R Romero, N Laham, et al.
Histopathology|July 18, 2006
Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clonesM B Loughrey, V Beshay, A Dobrovic, et al.
Journal of Clinical Pathology|June 25, 2005
Gastrointestinal stromal tumour treated with neoadjuvant imatinibM B Loughrey, C Mitchell, G B Mann, et al.
Arthritis and Rheumatism|July 1, 1993
Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritidesP M Waring, G J Carroll, D A Kandiah, et al.
Clinical and Experimental Immunology|December 1, 1995
Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemiaP M Waring, J Presneill, D W Maher, et al.
Critical Care Medicine|November 5, 1999
Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study GroupJ H Reeves, W W Butt, F Shann, et al.
Familial Cancer|April 25, 2007
Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancerM B Loughrey, P M Waring, A Tan, et al.
Critical Care Medicine|August 2, 2000
Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortalityJ J Presneill, P M Waring, J E Layton, et al.
Histopathology|July 18, 2006
KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinibM B Loughrey, M Trivett, V Beshay, et al.
Pageof 2